- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01004627
A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery
July 10, 2019 updated by: Hull University Teaching Hospitals NHS Trust
A Prospective Randomized Controlled Trial of the Clinical Effectiveness of Obligatory Versus Elective Duplex Ultrasound Scanning Prior to Arteriovenous Fistula Formation for Haemodialysis Vascular Access in a University Teaching Hospital.
Dialysis patients have their blood filtered by a machine as their kidneys no longer work.
To get blood in and out of these patients it is possible to perform a surgical procedure to increase to size and durability of a vein in the arm to allow repeated needle insertion.
This enlarged vein is called a fistula.
There is some evidence that ultrasound scanning the blood vessels in the arm before surgery can improve the chances of a successful procedure.
The investigators aim to test whether scanning all patients is better than scanning only those who are difficult to assess by physical examination alone.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
We will recruit all patients undergoing primary vascular access procedures in our unit who meet inclusion criteria.
They will be randomised to either surgery based on clinical findings with duplex ultrasound only if requested by surgeon, or routine duplex ultrasound prior to surgery.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hull, United Kingdom, HU3 2JZ
- Hull Royal Infirmary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Specific inclusion criteria necessary for invitation to study participation; Patients referred to vascular consultants for primary AV fistula formation (or primary fistula in that limb) for haemodialysis access.
General inclusion criteria;
- Ability to give informed written consent
Exclusion Criteria:
Specific exclusion criteria;
- Previous arterial or venous surgery/intervention performed on target limb.
- Known thrombophilic or thrombotic pathology.
- Aged under 18 at time of referral
General exclusion criteria;
- Inability to give informed written consent
- Inability to attend follow up appointments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group - selective duplex
Patients will receive a duplex ultrasound only if specifically requested following physical examination.
|
|
|
Experimental: Obligatory Duplex scan
Patients will receive a duplex ultrasound regardless of clinical findings.
Arterial and venous duplex ultrasound examination
|
Ultrasound mapping of all blood vessels in the upper limb of interest
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Primary failure of access (immediate/early thrombosis or failure to mature).
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assisted primary patency - being the interval from placement until the time of measurement of patency, including intervening manipulations
Time Frame: open ended
|
open ended
|
|
Secondary patency - The interval from placement until time of patency measurement including intervening manipulations
Time Frame: open ended
|
open ended
|
|
Site of fistula created
Time Frame: within 1 month of recruitment
|
within 1 month of recruitment
|
|
Functional primary patency - being the interval from the time of access placement until any intervention designed to maintain or re-establish patency or the time of measurement of patency during which the AVF provides dialysis access.
Time Frame: open ended
|
open ended
|
|
Surgeon grade
Time Frame: open ended
|
open ended
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microparticle concentration
Time Frame: open
|
Blood tests will be taken at baseline, 1, 3 and 6 months to investigate the impact of concentrations on patency
|
open
|
|
Circulating tissue factor concentration
Time Frame: open
|
Blood test to be taken at baseline, 1, 3 and 6 months and examined using ELISA to establish the impact of tissue factor concentrations on patency
|
open
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ian C Chetter, MBChB FRCS MD, Hull University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
October 29, 2009
First Submitted That Met QC Criteria
October 29, 2009
First Posted (Estimate)
October 30, 2009
Study Record Updates
Last Update Posted (Actual)
July 12, 2019
Last Update Submitted That Met QC Criteria
July 10, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Access 1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
Clinical Trials on Arterial and venous duplex ultrasound examination
-
The University of Texas Medical Branch, GalvestonWithdrawnPregnancy | ObeseUnited States
-
Mercedes Segunda Peralta GámezUniversity Rovira i VirgiliCompletedArterial Blood Pressure | Difficult Vein AccessSpain
-
Hospices Civils de LyonCompletedSeverely Traumatized Patients in Emergency WardsFrance
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
-
University Hospital, LinkoepingCompletedCOVID-19 | SARS-CoV 2 | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary EmbolismSweden
-
University of BolognaActive, not recruiting
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedCOVID-19 | Critical Illness | Venous Thromboembolism | SARS-CoV Infection | Pulmonary Embolism | Sars-CoV2 | Venous Thromboses | Pulmonary Embolism and Thrombosis | Venous Thromboses, Deep | Venous Thrombosis PulmonarySpain
-
Thomas Jefferson UniversityCompletedErectile Dysfunction | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
Imperial College LondonCompletedMay-Thurner SyndromeUnited Kingdom
-
Prince of Songkla UniversityCompletedCongenital Heart Disease | Perioperative/Postoperative Complications | Lactate Blood IncreaseThailand